Radiation Therapy Approaches for People With Prostate Cancer
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Trial Details
- NCT ID
- NCT07751159
- Phase
- PHASE2
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Cancer Type
- Prostate Cancer
- Interventions
- Standard of Care HDR Brachytherapy
- SBRT
- Locations (sample)
- Basking Ridge, New Jersey, United States|40.70621,-74.54932
- Middletown, New Jersey, United States|40.39428,-74.11709
- Montvale, New Jersey, United States|41.04676,-74.02292
- Commack, New York, United States|40.84288,-73.29289
- Harrison, New York, United States|40.96899,-73.71263
Key Eligibility Criteria
- Non-metastatic prostate cancer.
- Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or …
- Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Prostate Cancer Trials on Trialify →